Skip to content

US · ACTU

Actuate Therapeutics Inc

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
Fort Worth, TX 76107

Price · as of 2026-09-04

$1.48

Market cap 27.04M

Price history

Weekly OHLC price history for ACTU, USD per share
WeekOpenHighLowCloseVolume
Aug 12, 2024 – Aug 16, 2024$9.88$10.17$7.33$8.700
Aug 19, 2024 – Aug 23, 2024$8.94$9.00$7.97$8.080
Aug 26, 2024 – Aug 30, 2024$7.98$8.50$7.91$8.050
Sep 2, 2024 – Sep 6, 2024$8.20$8.26$7.96$8.150
Sep 9, 2024 – Sep 13, 2024$7.99$8.47$7.50$8.010
Sep 16, 2024 – Sep 20, 2024$7.88$8.46$7.01$7.310
Sep 23, 2024 – Sep 27, 2024$7.32$7.70$5.51$6.270
Sep 30, 2024 – Oct 4, 2024$6.50$7.80$6.37$7.460
Oct 7, 2024 – Oct 11, 2024$7.29$7.50$6.80$7.350
Oct 14, 2024 – Oct 18, 2024$7.49$8.50$7.16$7.260
Oct 21, 2024 – Oct 25, 2024$7.45$8.90$6.77$8.520
Oct 28, 2024 – Nov 1, 2024$8.60$9.87$7.28$7.830
Nov 4, 2024 – Nov 8, 2024$8.17$9.39$8.09$8.760
Nov 11, 2024 – Nov 15, 2024$8.84$9.39$8.31$8.680
Nov 18, 2024 – Nov 22, 2024$8.69$9.38$8.58$8.980
Nov 25, 2024 – Nov 29, 2024$8.88$9.72$7.89$8.130
Dec 2, 2024 – Dec 6, 2024$8.15$9.34$7.87$8.950
Dec 9, 2024 – Dec 13, 2024$8.81$9.20$7.62$8.620
Dec 16, 2024 – Dec 20, 2024$8.81$10.09$6.63$6.770
Dec 23, 2024 – Dec 27, 2024$6.94$8.93$6.27$8.840
Dec 30, 2024 – Jan 3, 2025$9.02$9.02$7.48$8.330
Jan 6, 2025 – Jan 10, 2025$8.62$8.67$7.69$8.300
Jan 13, 2025 – Jan 17, 2025$7.99$9.14$7.65$8.620
Jan 20, 2025 – Jan 24, 2025$8.87$11.73$8.70$10.110
Jan 27, 2025 – Jan 31, 2025$10.06$10.80$8.44$9.030
Feb 3, 2025 – Feb 7, 2025$8.87$9.95$8.39$8.810
Feb 10, 2025 – Feb 14, 2025$8.80$9.01$7.13$7.760
Feb 17, 2025 – Feb 21, 2025$7.50$7.99$6.72$7.690
Feb 24, 2025 – Feb 28, 2025$7.29$7.99$6.60$7.240
Mar 3, 2025 – Mar 7, 2025$7.24$7.45$6.02$6.950
Mar 10, 2025 – Mar 14, 2025$7.01$7.75$6.92$7.250
Mar 17, 2025 – Mar 21, 2025$7.48$7.49$6.60$6.750
Mar 24, 2025 – Mar 28, 2025$6.76$8.37$6.67$7.900
Mar 31, 2025 – Apr 4, 2025$7.49$7.98$6.10$6.890
Apr 7, 2025 – Apr 11, 2025$6.79$7.94$6.42$7.660
Apr 14, 2025 – Apr 17, 2025$8.15$8.26$7.31$8.000
Apr 21, 2025 – Apr 25, 2025$8.00$9.40$7.59$8.950
Apr 28, 2025 – May 2, 2025$8.98$10.53$8.82$10.530
May 5, 2025 – May 9, 2025$10.33$10.62$8.07$10.350
May 12, 2025 – May 16, 2025$10.48$10.74$9.28$10.550
May 19, 2025 – May 23, 2025$10.25$11.32$9.74$10.330
May 26, 2025 – May 30, 2025$10.46$11.99$10.31$11.900
Jun 2, 2025 – Jun 6, 2025$11.70$11.70$8.37$8.960
Jun 9, 2025 – Jun 13, 2025$9.10$9.35$8.24$8.650
Jun 16, 2025 – Jun 20, 2025$8.75$8.90$7.27$7.470
Jun 23, 2025 – Jun 27, 2025$7.35$7.37$5.50$5.960
Jun 30, 2025 – Jul 3, 2025$5.88$6.87$5.60$6.590
Jul 7, 2025 – Jul 11, 2025$6.59$6.75$5.70$6.140
Jul 14, 2025 – Jul 18, 2025$6.16$7.33$5.76$5.760
Jul 21, 2025 – Jul 25, 2025$5.70$7.28$5.47$7.260
Jul 28, 2025 – Aug 1, 2025$7.19$7.33$6.58$7.260
Aug 4, 2025 – Aug 8, 2025$7.26$8.43$6.81$8.020
Aug 11, 2025 – Aug 15, 2025$7.95$8.99$7.76$8.120
Aug 18, 2025 – Aug 22, 2025$8.12$8.57$7.46$8.360
Aug 25, 2025 – Aug 29, 2025$8.15$8.55$7.74$8.440
Sep 1, 2025 – Sep 5, 2025$8.46$9.22$8.14$8.240
Sep 8, 2025 – Sep 12, 2025$8.24$8.55$6.31$6.670
Sep 15, 2025 – Sep 19, 2025$6.74$7.19$6.60$6.640
Sep 22, 2025 – Sep 26, 2025$6.70$7.25$6.53$6.890
Sep 29, 2025 – Oct 3, 2025$6.90$7.12$6.64$6.980
Oct 6, 2025 – Oct 10, 2025$6.97$8.49$6.82$7.790
Oct 13, 2025 – Oct 17, 2025$7.78$8.30$7.27$7.480
Oct 20, 2025 – Oct 24, 2025$7.47$7.62$7.01$7.200
Oct 27, 2025 – Oct 31, 2025$7.20$7.34$6.30$6.660
Nov 3, 2025 – Nov 7, 2025$6.67$7.01$6.01$6.140
Nov 10, 2025 – Nov 14, 2025$6.12$6.38$5.66$5.910
Nov 17, 2025 – Nov 21, 2025$5.83$6.33$5.61$6.310
Nov 24, 2025 – Nov 28, 2025$6.38$7.79$5.80$7.630
Dec 1, 2025 – Dec 5, 2025$7.50$7.64$7.05$7.350
Dec 8, 2025 – Dec 12, 2025$7.48$7.90$6.89$7.520
Dec 15, 2025 – Dec 19, 2025$7.63$7.70$6.64$6.980
Dec 22, 2025 – Dec 26, 2025$6.95$7.25$6.34$6.470
Dec 29, 2025 – Jan 2, 2026$6.47$6.68$5.75$6.030
Jan 5, 2026 – Jan 9, 2026$6.26$7.05$5.83$6.140
Jan 12, 2026 – Jan 16, 2026$6.15$6.20$5.08$5.690
Jan 19, 2026 – Jan 23, 2026$5.62$5.89$5.11$5.310
Jan 26, 2026 – Jan 30, 2026$5.34$5.76$4.57$4.710
Feb 2, 2026 – Feb 6, 2026$4.73$5.15$4.14$4.410
Feb 9, 2026 – Feb 13, 2026$4.40$4.43$4.04$4.330
Feb 16, 2026 – Feb 20, 2026$4.35$4.49$4.06$4.130
Feb 23, 2026 – Feb 27, 2026$4.22$4.44$3.72$3.740
Mar 2, 2026 – Mar 6, 2026$3.60$3.94$2.73$2.860
Mar 9, 2026 – Mar 13, 2026$2.89$3.11$2.33$2.560
Mar 16, 2026 – Mar 20, 2026$2.55$2.80$2.27$2.350
Mar 23, 2026 – Mar 27, 2026$2.40$2.54$2.05$2.150
Mar 30, 2026 – Apr 2, 2026$2.15$2.94$2.09$2.480
Apr 6, 2026 – Apr 10, 2026$2.43$2.60$1.69$1.720
Apr 13, 2026 – Apr 17, 2026$1.72$2.59$1.58$2.310
Apr 20, 2026 – Apr 24, 2026$2.49$3.10$2.24$2.970
Apr 27, 2026 – May 1, 2026$2.99$3.19$2.64$3.000
May 4, 2026 – May 8, 2026$2.98$3.43$2.81$3.300
May 11, 2026 – May 15, 2026$3.27$3.35$2.61$2.620
May 18, 2026 – May 22, 2026$2.60$2.81$2.31$2.380
May 25, 2026 – May 29, 2026$2.42$2.50$1.96$2.020
Jun 1, 2026 – Jun 5, 2026$2.18$2.25$1.81$1.880
Jun 8, 2026 – Jun 12, 2026$1.92$2.78$1.77$2.020
Jun 15, 2026 – Jun 18, 2026$2.14$2.16$1.93$2.070
Jun 22, 2026 – Jun 26, 2026$2.15$2.33$1.68$1.680
Jun 29, 2026 – Jul 2, 2026$1.73$1.76$1.40$1.520
Jul 6, 2026 – Jul 10, 2026$1.52$1.57$1.16$1.210
Jul 13, 2026 – Jul 17, 2026$1.25$1.95$1.25$1.440
Jul 20, 2026 – Jul 24, 2026$1.53$1.53$1.16$1.180
Jul 27, 2026 – Jul 31, 2026$1.17$1.24$1.03$1.110
Aug 3, 2026 – Aug 7, 2026$1.14$1.25$1.02$1.110
Aug 10, 2026 – Aug 14, 2026$1.13$1.14$0.90$1.010
Aug 17, 2026 – Aug 21, 2026$1.02$1.34$0.95$1.270
Aug 24, 2026 – Aug 28, 2026$1.28$1.97$1.18$1.660
Aug 31, 2026 – Sep 4, 2026$1.64$1.73$1.26$1.480

Valuation

MetricValueUpside
IC Value
P/E-2.42
P/B6.79
P/S
EV/EBITDA-1.85
PEG
P/TBV6.79

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for ACTU, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024$6.95
2025$2.56

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Actuate Therapeutics Inc

        Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.

        CEO
        Daniel Schmitt
        Employees
        12
        Beta
        0.78

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for ACTU: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        ACTUActuate Therapeutics Inc$1.1127.04M-2.426.79-1.856.790.00%0.00%0.00%-553.75%336.56%-190.35%0.05-1110.882.392.310.57-67.48%-12.07%-35.69%-3.37287.35%0.00%0.00%7.64%-1.83-2.14-14.75
        ALECAlector, Inc.$1.49165.43M$14.39+865%-1.597.3910.77-0.05-12.197.3954.09%-692.83%-679.16%-181.56%67.31%-37.54%1.183.833.680.2213.01%-79.07%-20.37%-81.23%-2.6584.98%0.00%0.00%17.24%-0.05-0.040.32-4.89
        ELTXElicio Therapeutics, Inc.$3.1960.82M-4.72114.19-4.90114.190.00%0.00%0.00%817.92%1421.83%-146.45%8.87-33.292.382.290.11-39.29%-0.50%-19.79%-4.561393.70%0.00%0.00%6.68%-4.85-4.94-12.32
        MCRBSeres Therapeutics, Inc.$5.0148.47M13.421.7396.9011.561.73-423.83%-11910.14%721.93%19.64%-120.44%4.10%1.882.562.393.78-103.39%-100.58%1.13%0.061.11%0.00%0.00%30.93%-1.21131.39144.05-11.34
        MOLNMolecular Partners AG$4.01150.42M$3.57-11%-2.061.58-0.63-54.601.580.00%0.00%0.00%-55.55%805.15%-47.31%0.05-3229.118.798.611.333.77%-100.00%-13.34%-40.92%-4.65719.92%0.00%0.00%13.84%-0.65-0.72-1.64
        NKTXNkarta, Inc.$2.20157.4M-1.610.540.340.540.00%0.00%0.00%-28.90%-72.72%-22.99%0.2412.6912.50-0.39-11.88%-13.64%-53.77%-3.98-53.94%0.00%0.00%9.34%0.270.36-1.37
        PEPGPepGen Inc.$1.98136.96M-2.511.52-1.061.520.00%0.00%0.00%-67.39%-565.94%-55.21%0.1211.9411.740.49-25.61%-1.17%-36.43%-6.46-495.13%0.00%0.00%5.67%-1.00-1.141.37
        SPROSpero Therapeutics, Inc.$1.2672.96M$21.25+1,586%16.862.452.4212.132.45100.00%-0.04%14.38%16.31%-0.24%9.55%0.057.597.40-4.23-111.81%24.27%-46.15%-8.73%-1.42-131.62%0.00%0.00%0.00%-4465.11-8.491.801.48
        VORVor Biopharma Inc.$22.271.21B-0.19-0.810.46-0.18-0.810.00%0.00%0.00%2057.65%128.16%-229.31%-0.0218.2018.080.57107.35%43.81%-107.71%-5.6749.54%0.00%0.00%257.46%0.862.22-4.87
        VTGNVistaGen Therapeutics, In…$0.3012.19M$18.27+6,052%-0.300.5816.200.33-3.080.58100.00%-5683.69%-5491.33%-131.59%827.99%-104.86%0.033.673.550.429.58%161.11%57.46%-323.87%-5.19764.40%0.00%0.00%0.00%0.330.36-18.75-16.85

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $1.48) − 1 = — (IC, example).